Biotech Startups

SpringWorks is a biotechnology company focused on developing innovative treatments for cancer patients. The company combines rigorous scientific research with an operational commitment to rapidly advance therapeutic solutions.

2 investors

Spyre develops and commercializes treatments for a broad range of diseases focused on improving patient outcomes.

2 investors

SQIM is a material innovation company that uses living organisms and organic matter (biofabrication) to produce alternative materials. It operates two product brands: Ephea, which makes mycelium-based materials for fashion, and Mogu, which makes materials for interior design and architecture.

2 investors

2 investors

STAQ Pharma is an FDA-registered 503B outsourcing facility that compounds and supplies medications to hospitals and healthcare providers across the United States, aiming to address drug shortages. The company is owned and guided by several healthcare systems and focuses on safety, transparency, availability, and quality.

2 investors

Starling Medical develops smart devices and predictive learning solutions focused on preventative bladder health and urinary tract infection management. The company combines digital health technology with clinical analytics to augment standard UTI care.

2 investors

2 investors

Stimdia Medical develops neuromodulation technologies, with a leadership team focused on clinical and regulatory affairs and R&D in critical care and pulmonary medicine. The company operates in the medical device sector.

2 investors

StimOxyGen develops advanced nanoparticle-based therapies using sonodynamic and oxygen-generating technology for oncology and wound healing. The company focuses on addressing unmet medical needs in cancer treatment and tissue regeneration.

2 investors

Stirling Ultracold builds ultra-low temperature (ULT) freezers based on free-piston Stirling engine technology, offering high-density storage with lower energy consumption than conventional units. Its freezers serve research labs, hospitals, and cancer centers, and are sold directly and through laboratory supply distributors worldwide.

2 investors

Strata Oncology develops precision oncology biomarkers and predictive diagnostic tools for cancer treatment, including treatment response scores for antibody-drug conjugates (ADCs) and an Immunotherapy Response Score for anti-PD-1/PD-L1 therapies. Its algorithms combine measures such as tumor mutation burden and gene expression to help match patients to the most suitable therapy.

2 investors

StrataGen Bio develops technology to convert MRI scans into quantitative biomarker measurements for objective clinical decision-making. The company operates in the medical imaging and diagnostics space.

2 investors

StratifAI develops Polaris, an AI platform that links histology, RNA-seq, and patient outcomes to analyze spatial biology for cancer research. Its first diagnostic, Polaris Breast, assesses metastatic risk in early breast cancer from digitized histology slides and is currently for research use only while pursuing regulatory approval in the EU and US.

2 investors

String Bio develops technology at the intersection of biology, engineering, and chemistry to produce next-generation ingredients addressing challenges in food, feed, health, and the environment. The company operates a proprietary technology platform and a product portfolio aimed at sustainable and scalable bio-based solutions.

2 investors

SugaROx develops precision crop biostimulants using patented chemical-caging technology to deliver single-molecule formulations that improve plant metabolism and stress responses, targeting staple crops including wheat, barley, soybean, and maize for agricultural markets.

2 investors

Sun Bear Biofuture develops genetically modified yeast that produces oil through precision fermentation for sustainable food production. The company targets the fats and oils industry with a focus on reducing environmental impact from conventional agriculture.

2 investors

Flore creates personalized probiotics based on individual microbiome sequencing, analyzing gut health markers to formulate targeted probiotic blends for each customer. The company serves consumers seeking customized solutions for digestive and gut-brain health issues.

2 investors

Sunstone Therapies is a clinical research organization with expertise in psychedelic and consciousness research, operating with teams that include researchers from institutions like Johns Hopkins Center for Psychedelic and Consciousness Research and the Dana-Farber Cancer Institute. The company focuses on patient-centered care with clinical rigor in the mental health and oncology spaces.

2 investors

Superbrewed Food produces SB1, an FDA-GRAS postbiotic cultured protein ingredient made through anaerobic fermentation of bacteria, offering a non-GMO, high-protein alternative for use in food and beverage products such as cheese and meat alternatives. The company sells the ingredient to food manufacturers and has collaborated with partners including Fonterra, Bel, and Döhler.

2 investors

Surf Bio is a preclinical biopharmaceutical company developing its SnapShot technology, which uses a proprietary polymer to create ultra-high-concentration antibody and biologic formulations (600+ mg/mL, doses over 1,000 mg) for delivery via a standard autoinjector. The technology enables at-home subcutaneous self-injection of monoclonal antibodies and biologics as an alternative to in-clinic IV infusion, and is offered to pharmaceutical API manufacturers through partnerships.

2 investors

Sutro is a biotech company developing a cell-free protein synthesis platform for the design and manufacturing of complex biologics, particularly cancer therapies and antibody-drug conjugates.

2 investors

Sword Bio is a bioanalytical contract research organization providing assay development and testing services for pharmaceutical and biotechnology companies across preclinical through Phase IV clinical trials. The company specializes in pharmacokinetics, biomarker analysis, and immunogenicity assessment for large molecule, gene therapy, and cell therapy biotherapeutics.

2 investors

Symeres provides pharmaceutical quality management systems, drug discovery and development services, and contract manufacturing support for biotech and pharma companies. The company operates GMP, GLP, and ISO-certified facilities across Europe and North America to support molecules from early discovery through regulatory submission and manufacturing.

2 investors

Synaffix develops antibody-drug conjugate (ADC) technology, providing linker-payload platforms that attach small-molecule, peptide, and protein-based payloads to antibodies for use in targeted cancer therapies. The company has been integrated into Lonza's Advanced Synthesis business platform.

2 investors